Psychooncology. New aspects for urology;Psychoonkologie: Neue aspekte für die urologie

Urologe - Ausgabe A

Volumn 43, Issue 3, 2004, Pages 296-301

  Kollner V ^a,b   Lautenschlager K A ^a   Pajonk, F G ^c  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b Bliestal Kliniken   (Germany)

^c SAARLAND UNIVERSITY   (Germany)

Author keywords

Anxiety; Depression; Post traumatic stress disorder; Psychooncology; Urology

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR; CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; DIAZEPAM; DOXEPIN; LORAZEPAM; MIDAZOLAM; MIRTAZAPINE; OPIPRAMOL; OXAZEPAM; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; VENLAFAXINE;

ANXIETY DISORDER; CANCER PAIN; CANCER PATIENT; CLINICAL TRIAL; COMORBIDITY; COPING BEHAVIOR; DEPRESSION; DISEASE ASSOCIATION; DISTRESS SYNDROME; DOCTOR PATIENT RELATION; DRUG EFFICACY; DRUG SAFETY; HUMAN; MENTAL DISEASE; ONCOLOGY; PATIENT ATTITUDE; PATIENT CARE; POSTTRAUMATIC STRESS DISORDER; PROSTATE CANCER; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; PSYCHOPHARMACOLOGY; PSYCHOTHERAPY; REVIEW; SYMPTOM; WELLBEING;

ANXIETY; DEPRESSION; FEMALE; FEMALE UROGENITAL DISEASES; HUMANS; MALE; MALE UROGENITAL DISEASES; MIDDLE AGED; NEOPLASMS; PAIN; PHYSICIAN-PATIENT RELATIONS; STRESS DISORDERS, POST-TRAUMATIC; UROLOGIC DISEASES;

EID: 18544410420     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-003-0506-1     Document Type: Review

References (35)

1. Ben-Tovim DI, Dougherty ML, Stapleton AM, Pinnock CB (2002) Coping with prostate cancer: a quantitative analysis using a new instrument, the center for clinical excellence in urological research coping with cancer instrument. Urology 59/3: 383-388
2. Berberich HJ, Brähler E (2001) Prostatakarzinom, Krankheitsverlauf und Partnerschaft In: Brähler E, Kupfer J (Hrsg) Mann und Medizin, Jahrbuch der Medizinischen Psychologie 19. Hogrefe, Göttingen, S 234-247
3. Bisson JI, Chubb HL, Bennett S et al. (2002) The prevalence of psychological distress in patients with early localized prostate cancer. BJU Int 90/1: 56-61
4. Bratt O, Emanuelsson M, Gronberg H (2003) Psychological aspects of screening in families with hereditary prostate cancer. Scand J Urol Nephrol 37/1: 5-9
5. Cliff AM, MacDonagh RP (2000) Psychological morbidity in prostate cancer: II. A comparison of patients and partners. BJU Int 86/7: 834-839
6. Derra C, Egle UT (2003) Psychosomatische Aspekte bei Tumorschmerz. In: Egle UT, Hoffmann SO, Lehmann KA, Nix WA (Hrsg) Handbuch Chronischer Schmerz. Schattauer, Stuttgart, S 459-467
7. Fawcett J, Barkin RL (1998) Review of the results from clinical studies on the efficacy, safety and tolerability of mirtazapine for the treatment of patients with major depression. J Affect Disord 51/3: 267-285
8. Ficarra V, Righetti R, D'Amico A et al. (2000) General state of health and psychological well-being in patients after surgery for urological malignant neoplasmas. Urol Int 65/30: 130-134
9. Fossa SD, Dahl AA (2002) Short Form 36 and Hospital Anxiety and Depression Scale. A comparison based on patients with testicular cancer. J Psychosom Res 52/2: 79-87
10. Fossa SD, Dahl AA, Loge JH (2003) Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 21/7: 1249-1254
11. Gündel H Lordick F, Brandl T (2003) Psychoedukative Patientengruppen im Rahmen einer interdisziplinären Tumortherapie. Z Psychosom Med Psychother 49/3: 246-261
12. Hautzinger M (2000) Depression im Alter. Psychologie Verlags Union, Weinheim
13. Herrmann CH, Buss U, Snaith RP (1995) HADS-D: Hospital Anxiety and Depression Scale - Deutsche Version. Testdokumentation und Handanweisung. Huber, Bern
14. Herschbach P (2002) Das "Zufriedenheitsparadox" in der Lebensqualitätsforschung. Psychother Psych Med 52/3-4: 141-150
15. Husebø S, Klaschik E (2003) Palliativmedizin, 3. Aufl. Springer, Berlin Heidelberg New York Tokio, 5 329
16. Jones GY, Payne S (2000) Searching for safety signals: the experience of medical surveillance amongst men with testicular teratomas. Psychooncology 9/5: 385-394
17. Kangas M, Henry JL, Bryant RA (2002) Posttraumatic stress disorder following cancer. A conceptual and empirical review. Clin Psychol Rev 22/4: 499-524
18. Kienke AS, Rosenbaum JF (2000) Efficacy of venlafaxine in the treatment of severe depression. Depress Anxiety 12 (Suppl 1): 50-54
19. Köllner V (2002) Kognitive Verhaltenstherapie der Posttraumatischen Belastungsstörung. Fundam Psychiatr 16: 24-29
20. Langewitz W, Conen D, Nübling M, Weber H (2002) Kommunikation ist wesentlich - Defizite der Betreuung im Krankenhaus aus der Sicht von Patienten und Patientinnen. Psychother Psych Med 52/8: 348-354
21. Laux G, Dietmaier O, König W (2002) Psychopharmaka - Ein Leitfaden. Urban und Fischer, München
22. Möller HJ, Volz HP, Reimann IW, Stoll KD (2001) Opipramol for the treatment of generalized anxiety disorder: a placebo-controlled trial including an alprazolam-treated group. J Clin Psychopharmacol 21/1: 59-65
23. Nordin K, Berglund G, Glimelius B, Sjoden PO (2001) Predicting anxiety and depression among cancer patients: a clinical model. Eur J Cancer 37/3: 376-384
24. Pirl WF, Siegel GI, Goode MJ, Smith MR (2002) Depression in men receiving deprivation therapy for prostate cancer: a pilot study. Psychooncology 11/6: 518-523
25. Radbruch L, Sabatowski R, Lehmann KA (2003) Tumorschmerztherapie. In: Egle UT, Hoffmann SO, Lehmann KA, Nix WA (Hrsg) Handbuch Chronischer Schmerz. Schattauer, Stuttgart, S 488-459
26. Roth AJ, Rosenfeld B, Kornblith AB et al. (2003) The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with prostate cancer. Cancer 97/11: 2910-2918
27. Schwarz R, Stump S (1999) Onkologische Erkrankungen. In: Senf W, Broda M (Hrsg) Praxis der Psychotherapie. Thieme, Stuttgart, S 597-605
28. Spiegel D, Giese-Davis J (2003) Depression and cancer: mechanisms and disease progression. Biol Psychiatry 54/3: 269-282
29. Stasi R, Abriani L, Beccaglia P (2003) Cancer-related fatigue: evolving concepts in evaluation and treatment. Cancer 98/9: 1786-1801
30. Stockhorst U (2002) Krebserkrankungen. In: Ehlert U (Hrsg) Verhaltensmedizin. Springer, Berlin Heidelberg New York Tokio, S 327-366
31. Stommel M, Given BA, Given CW (2002) Depression and functional status as predictors of death among cancer patients. Cancer 94/10: 2719-2727
32. Teichmann JV (2002) Onkologische Rehabilitation: Evaluation der Effektivität stationärer Rehabilitation. Rehabilitation 41/1: 53-63
33. Ullrich PM, Carson MR, Lutgendorf SK, Williams RD (2003) Cancer fear and mood disturbance after radical prostatectomy: consequences of biochemical evidencde of recurrence. J Urol 169/4: 1449-1452
34. Valentine AD (2003) Cancer pain and depression: management of the dual-diagnosed patient. Curr Pain Headache Rep 7/4: 262-269
35. Weis J (2003) Support groups for cancer patients. Support Care Cancer 11/12: 763-768